Granzyme B enters the mitochondria in a Sam50-, Tim22- and mtHsp70-dependent manner to induce apoptosis by Chiusolo, Valentina et al.
Chiusolo et al   1 
Granzyme B enters mitochondria in a Sam50, Tim22 and mtHsp70-dependent manner to 
induce apoptosis. 
Valentina Chiusolo1#, Guillaume Jacquemin1#, Esen Yonca Bassoy1, Laurent Vinet2, 3, 
Lavinia Liguori4, Michael Walch5, Vera Kozjak-Pavlovic6 and Denis Martinvalet1*.  
 
Supplemental Material and Methods: 
Mice, cell lines and growth conditions 
The C57BL/6J wild-type female mice were obtained by the Animal Facility of the University 
of Geneva and used for liver mitochondrial purification in accordance with approved 
animal protocol by the cantonal veterinarian.  
Hela cells were grown in DMEM supplemented with 10% fetal calf serum, 100 U/ml 
penicillin G, 100 μg/ml streptomycin sulfate 6mM hepes free acid, 1.6 mM L-glutamine, 
and 50 μM β-mercaptoethanol. Hela-CD80 cells were grown in same medium plus 
puromycin. 721.221 cells overexpressing NDUFS1-V5-D255A were grown as in 
Jacquemin et al 201418. HeLa TOM40 sh and SAM50 sh were grown as in Ott, C 201549. 
Hela expressing doxycyclin (Dox)-inducible B2Δ19-HA or SU9-V5 were cultured in DMEM 
supplemented with Tet System Approved FBS (TAKARA Clontech). Hela cell and 721.221 
were used as target cells for NK cells.  
Parental YT-Indy were grown in RPMI 1640 supplemented with 10% fetal calf serum, 100 
U/ml penicillin G, 100 μg/ml streptomycin sulfate 6 mM hepes free acid, 1.6 mM L-
glutamine, and 50 μM β-mercaptoethanol. YT-Indy silenced for endogenously expressed 
granzyme B, K and M (YT-shGzm) were grown in same medium as parental YT Indy plus 
puromycin. YT-shGzm re-expressing either wild type GB (YT-wtGB), GB KR243-244AA 
(YT-KR/AA), wild type GA (YT-wtGA), or GM (YT-wtGM) were grown in same medium as 
parental YT Indy cells plus puromycin and blasticidin.  
 
Hela were from ATCC and 721.221 and YT-Indy was a kind gift of Pr. Lieberman. The 
cells were regularly tested for mycoplasma to unsure the usage of mycoplasma free cells.  
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YPH499 parental strain (MATa ade2-101 his3-'200 leu2-'1 trp1-'63 ura3=52 lys2-
801)54, YPH499 tom70::HIS337, YTJB4 MATa Leu2 His4 Lys232, YTJB64, tom20::LEU237,  
YPH499 'Mas37/Tob37, YPH499gal/his8-Tob5555, 'tom40+ pRS314-Tom40-2 KKY3.2 
(TK3), 'tom40+ pRS314-Tom40-3 KKY3.3 (TK4), 'tom40+ pRS314-Tom40-4 KKY3.4 
(TK5), thermosensitive strain for Tom40, and the wild type control 'tom40+ pRS314-
Tom40wt KKY3.7 (TK8)34 were kind gifts of Professor Doron Rapaport. PK80A parental 
strain (His4-713, Lys2, Ura3-52, 'Trp1, Leu2-3,112 wild type SSC1), thermosensitive 
strains for SSC1 PK81 SSC1-2 (Ade2-101, Lys2, Ura3-52, Leu2-3.112, 'Trp1 SSC1-
2(LEU2) and PK83 SSC1-3 (Ade21.1, Lys2, Ura3-52, 'Trp, SSCI-3(LEU2)) yeast strains 
were a kind gift of Professor Elizabeth Craig. The temperature-sensitive alleles Tim23-76 
(YPH-BG-TIM23-76), tim22-14 (YPH499 22-M4) were kind gift of Professor Nikolaus 
Pfanner and Dr. Bernard Guiard. Yeast strain M22-2-140 was a kind gift of Professor Marco 
Colombini. Yeast cells were grown under aerobic conditions in YPD (1% bacto yeast 
extract, 2% bactopeptone, and 2% glucose) or YPGal medium (1% bacto yeast extract, 
2% bactopeptone, and 2% galactose) depending on conditions. Single colony seed 
cultures were used to refresh larger cultures under shaking (~ 140 rpm). Mitochondrial 
purification was done when cultures reached OD600 0.8.  
 
Antibodies and reagents 
Antibodies against V5 (V5-10) and FLAG (M2), Proteinase k (PK), PMSF, doxycycline and 
Laminin were from Sigma Aldrich; anti-GzmB (GB7), anti-PARP (H-250), anti-HSP60 (H-
300), anti-tubulin (B-7), anti-Tom40 (H300), anti-SAMM50 (N-15), anti-HAX-1 (FL-279), 
anti-TIM44 (sc-21934), anti-yeast TIM23 yN-19 (sc-14048), donkey and-goat (sc-2020), 
and anti-NDUFS1 H-300 (sc-99232) were from Santa Cruz Biotechnology; anti-GzmA 
(GA6) from AbD Serotec; anti-GzmM (4D11) from Novus Biological; anti-HA (3F10) from 
Roche; anti-κ-light chain-HRP from Bethyl Laboratories; anti-Tom20 from BD Biosciences; 
anti-Caspase 3 (8G10) and anti-Histone H3 from Cell Signaling; anti-NDUFS1 from 
Epitomics; anti-GAPDH and anti-PORIN/VDAC1 (16G9E6BC4) from Abcam; Anti-mouse 
IgG-HRP, anti-rabbit IgG-HRP from GE Healthcare. Polyclonal anti-GB (PA5-17457), 
monoclonal anti-GB for immune fluorescence clone GB11 and Lipofectamine® 3000 were 
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from Thermo Fisher Scientific. Anti-Bid was from R&D system. Yeast anti-TOB55 and anti-
TOM40 were kind gifts from Professor Doron Rapaport and anti-yeast TOM20 was a kind 
gift of Professor Nikolaus Pfanner. Valinomycin, zVAD-fmk and DEVD-fmk were from 
Calbiochem. All enzymes for molecular cloning were from New England BioLabs® Inc. 
Plasmids encoding Rev-caspase 3 and C/A Rev caspase 3 were kind gifts of Professor 
Alnemri.  
 
In vitro Transcription/Translation. 
The pGEM®-4Z plasmid (Promega) was used as cloning vector for the in vitro synthesis 
of Dihydrofolate reductase (DHFR) and fusion proteins used in import assay experiments. 
DHFR was amplified by PCR from pQE60-Su9 (1-69) DHFR (kind gift of Dr. Dejana 
Mokranjac), cut either with EcoRI/NotI or NotI/BamHI, and inserted into pGEM®-4Z 
plasmid. The presequence of subunit 9 of the N. crassa F1F0-ATPase was amplified by 
PCR from pQE60- Su9 (1-69) DHFR and fused to the EcoRI/NotI digested pGEM®-4Z-
DHFR. N- and C-terminus of human granzyme B were obtained by primer annealing and 
fused to either EcoRI/NotI or NotI/BamHI digested pGEM®-4Z-DHFR. All constructs were 
sequence verified. 35S-Met-radiolabeled proteins were obtained from the TnT® SP6 High-
Yield Wheat Germ Protein Expression System (Promega) using 3 μg of DNA and 2 μl of 
35S-Met label (Hartmann analytic, IS-103).  
Primers for DHFR amplification:  
EcoRI-DHFR_Fw (AAAAAAGAATTCATGGTTCGACCATTGAACTGC) and DHFR-
NotI_Rv (ATGATGATTGCGGCCGCGCCGTCAAACTTATACTTGATG) for DHFR at 5’.  
NotI-DHFR_Fw (ACGACGGCGCGGCCGCAATCATGGTTCGACCATTG) and DHFR-
BamHI_Rv (TTTTTTGGATCCTTATTAAAACTTATACTTGATGCC) for DHFR at 3’. 
Primers for N- and C-terminal GzmB: 
3’Ct_Fw 
(GGCCGCGGTCTCAAGCTTTGTACACTGGATAAAGAAAACCATGAAACGCTACTAAT
AAGATATCG), 
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 3’Ct_Rv 
(GATCCGATATCTTATTAGTAGCGTTTCATGGTTTTCTTTATCCAGTGTACAAAGCTT
GAGACCGC) for DHFR-Ct construct;  
5’Ct_Fw 
(AATTCGATGGTCTCAAGCTTTGTACACTGGATAAAGAAAACCATGAAACGCTACAG
GCCTGC), 
5’Ct_Rv 
(GGCCGCAGGCCTGTAGCGTTTCATGGTTTTCTTTATCCAGTGTACAAAGCTTGAGA
CCATCG) for Ct-DHFR construct; 
3’Nt_Fw 
(GGCCGCGATCATCGGGGGACATGAGGCCAAGCCCCACTCCCGCCCCTACTAATA
AAGGCCTG),  
3’Nt_Rv 
(GATCCAGGCCTTTATTAGTAGGGGCGGGAGTGGGGCTTGGCCTCATGTCCCCCG
ATGATCGC) for DHFR-Nt construct;  
5’Nt_Fw 
(AATTCGATGATCATCGGGGGACATGAGGCCAAGCCCCACTCCCGCCCCTACAGG
CCTGC), 
5’Nt_Rv  
(GGCCGCAGGCCTGTAGGGGCGGGAGTGGGGCTTGGCCTCATGTCCCCCGATGAT
CATCG) for Nt-DHFR construct. 
Isolation of yeast mitochondria. 
Yeast mitochondria were isolated by differential centrifugation according to a published 
method56 with some minor modifications: 1 mM sodium orthovanadate (Na3VO4); 0.2 μM 
okadaic acid (C44H68O13) phosphatase inhibitors were added at the homogenization step 
and in the final resuspension of the mitochondrial pellet while BSA was omitted. 
Mitochondria concentration was measured by Pierce™BCA Protein Assay kit (Thermo 
Fisher). Yeast mitochondria were aliquoted and stored at -80oC.   
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Isolation of mouse liver mitochondria. 
Intact mouse liver mitochondria were purified according to a published method57, 
resuspended in IBc buffer (10 mM Tris-MOPS, 1 mM EGTA/Tris, 0.2 M sucrose, pH 7.4) 
plus 1 mM sodium orthovanadate (Na3VO4), and 0.2 μM okadaic acid (C44H68O13) 
phosphatase inhibitors, then used immediately. 
 
Mitochondrial import assay. 
Import assays were performed in mouse liver mitochondria (1.6 mg/ml) or yeast 
mitochondria (2 mg/ml). 30μl of mitochondria were incubated with 5 μL of 35S-Met-
radiolabeled or 0.2 μM  purified granzyme in import buffer (1.2 M sorbitol, 160 mM KCl, 
20 mM Mg-acetate, 4 mM KH2PO4, 5 mM EDTA, 5 mM MnCl2, 100 mM HEPES-KOH, pH 
7.2 plus 2.5 mM ATP, 5 mM NADH, 0.25 μg/ml creatine phosphokinase, and 25 mM 
creatine phosphate) or SH buffer (0.6 M Sorbitol, 20 mM Hepes-KOH, pH 7.4) in the 
presence or absence of 4 μM valinomycin. Samples in SH+ valinomycin buffer were 
preincubated for 10 minutes at RT. All the samples were then incubated at 37°C (mouse 
mitochondria) or 25°C (yeast mitochondria) for 15 minutes or indicated time. After 
incubation, half of the sample was kept untreated (INPUT) and the rest treated with 50 
μg/ml PK in a final volume of 1 ml SH buffer for 10 minutes on ice (IMPORTED). Then, 
PK was inhibited by adding 1 mM PMSF (phenylmethylsulfonyl fluoride) for 10 minutes on 
ice. Mitochondria were spun down at 12000 g for 15 minutes and resuspended in loading 
buffer to perform Western blot. The lanes -PK represent the total amount of GB bound 
(specifically or not) and unbound to the mitochondria. The % of import determined by 
densitometry and calculated as followed: 
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Where the (+PK) and the (-PK) were always normalized with their respective loading 
control. 
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Submitochondrial localization of proteins.  
Swelling experiments were performed from freshly isolated yeast mitochondria (0,8 
mg/ml). Granzymes (0.2μM) were incubated with mitochondria in import buffer to a final 
volume of 30μl for 15 minutes at 25°C. The samples were spun down at 12’000 g, for 5 
minutes at 4°C, resuspended in 400μl of isotonic SET buffer (250mM sucrose; 10mM 
Tris/HCl pH7.6; 1mM EDTA. ET buffer: 10mM Tris/HCl pH 7.6; 1mM EDTA) or hypotonic 
ET buffer (10 mM Tris/HCl pH 7.6 1 mM EDTA) for swelling and incubated for 30 minutes 
on ice. Swelled samples were occasionally vortexed to favor the generation of mitoplasts. 
The samples were the spun and the –PK resuspended in 5x loading buffer, while the +PK 
were resuspended in 100μl of SET buffer plus PK to a final concentration of 50μg/ml and 
incubated for 15 minutes on ice. PK was inhibited with 4mM PMSF for 10 minutes on ice. 
Samples were spun down and resuspended in 1x loading buffer. One sample was 
resuspended in 50μl of 1% Triton for 10 minutes on ice and then spun down at 14’000 
rpm at 4°C. The supernatant was treated with PK and PMSF as before and the 5x sample 
buffer was added. 
 
Mitochondrial '<m measurement. 
To assess '<m, YPH499 and M22-2-1 mitochondria (1 mg/ml) were incubated with 1.5 
μM of JC-1 to a final volume of 30 μl in import buffer (see mitochondrial import assay) for 
15 minutes at RT. Mitochondria were washed two times with SH buffer. Mitochondria were 
then analyzed by flow cytometry with an AccuriC6 flow cytometer (BD Biosciences). 
 
 
Blue Native gel. 
30μl of yeast mitochondria at 2 mg/ml were incubated with 0.2 μM biotinylated granzyme 
in import buffer for the indicated time at 250C. The samples were spun at 12000 g and 
mitochondrial pullet resuspended in BN gel lysis buffer (20 mM Tris pH7.4, 0.1 mM EDTA, 
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50 mM NaCl, 10% glycerol and 1% digitonin freshly added. We added 1 μl of 0.2 M of 
PMSF to avoid protein degradation. After 30 minutes samples were spun at 12000 g and 
40 μl of supernatant were combined with 6 μl of 50% glycerol and 5 μl of 5% coomassie 
blue. These samples were run directly on precast 3-12% gradient NativePAGE from 
Invitrogen Thermo Fisher. Gels were equilibrated for 30 minute with 1x transfer buffer 
without ethanol and blotted for 2 hours at 150 mA on PVDF membrane using a semi-dry 
transfer apparatus. Membranes were fixed for 20 minutes with 100% methanol before 
blocking in 5% non-fat milk and either incubated for 1 hour at room temperature with 
streptavidin HRP or probed with either anti-yeast Tob55 or yeast Tom40 primary antibody. 
 
Lactococcus lactis cloning and import assay. 
The NICE® lactococcus lactis expression strain NZ9100 (MoBiTec GmbH, Germany) was 
cultured at 30°C in M17 containing 0.5% Glucose, 20 mM MgCl2, and 2 mM CaCl2. 
Bacteria were electroporated according to the manufacturer’s protocol with the expression 
plasmid pNZ8148 containing the coding sequence of yeast Tom40, Tob55 or Por1. The 
cDNA encoding for yeast Por1, Tom40 and Tob55/Sam50 were a kind gift of Professor 
Doron Rapaport. 
Primers for cloning into pNZ8148: 
Yeast Tom40 FW: AAAAAAAGCTTATAAAGGAGGTAAAAAATGTCTGCACCAACTCC 
Yeast Tom40 RV: AAAAAAAGCTTTCACAATTGAGGAAGAG 
Yeast Por1 (VDAC1) FW:  
AAAAAGGTACCATAAAGGAGGTAAAAAATGTCTCCTCCAGTTTAC 
Yeast Por1 (VDAC1) RV: AAAAAAAGCTTTCAAGCGTCGAAGGAC 
Yeast Tob55 (Sam50) FW: 
 AAAAAGGTACCATAAAGGAGGTAAAAAATGACCTCATCATCTGG 
Yeast Tob55 (Sam50) RV: AAAAAAAGCTTTTATAAAAATGCCAGACCAAGAC 
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After selection with 10 μg/ml chloramphenicol on M17agar plates, the clones expressing 
Tom40, Tob55 or Por1 were grown until O.D.600 = 0.5 before addition of 100 ng/ml Nisin. 
After overnight incubation at 30°C with vigorous shaking, the cell wall was removed with 
1 mg/ml lysozyme for 5 minutes at 37°C, washed with PBS, and incubated with 400 nM 
GB for 15 minutes at 37°C. These two steps were done in presence of 1 mM sodium 
orthovanadate and 0.2 μM okadaic acid phosphatase inhibitors. Half of the sample was 
stored (INPUT), and the rest was treated with 50 μg/ml of proteinase K in a final volume 
of 1 ml PBS for10 minutes on ice. PK was then inhibited by adding 1 mM PMSF for 10 
minutes on ice. The samples were spun and resuspended in loading buffer (IMPORTED). 
For Western blot, 5 μl of input and 20 μl of imported samples were loaded. 
 
Confocal microscopy. 
HeLa cells transfected with Mito-RFP (Clontech) and ZsGreen-Gzms were used. ZsGreen 
was amplified by PCR from pZsGreen 1-1 plasmid (Clontech) and cut with NotI and BamHI 
or PacI restriction enzymes. Gzms cDNA were amplified by PCR from Origene vectors 
(GzmB: RC206495; GzmA: RC204852; GzmH: SC126062; GzmK: RC207798; GzmM: 
RC206497) and digested with BamHI and EcoRI restriction enzymes or PacI and EcoRI 
in the case of GH. ZsGreen and Gzms were ligated together in pQCXIP plasmid 
(Clontech). HeLa cells were plated at a density of ~2 × 104 cells in 24-well plates on 
coverslips overnight. Cells were transfected in serum free medium with Lipofectamine® 
2000 (Life Technologies), and after two hours, transfection medium was changed with 
complete medium. 24 hours later cells were fixed and coverslips mounted. Confocal 
microscopy images were obtained from a Zeiss LSM700 confocal microscopy with a 63x 
objective and analyzed by ImageJ software. ImageJ “Colocalization Threshold” plug-in 
was used to determine Mander’s coefficient. 
Primers for ZsGreen-Gzm cloning: 
ZsGreen_Fw: AAAAAAGCGGCCGCCGCCACCATGGCCCAGTCCAA 
(BamHI) ZsGreen_Rv: AAAAAAGGATCCACCACCACCACCACCGGGCAAGGCGGAG 
or 
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(PacI) ZsGreen_Rv: AAAAAATTAATTAAACCACCACCACCACCGGGCAAGGCGGAG 
The linker between ZsGreen and Gzms is in bold. 
Wild type GB_Fw: AAAAAAGGATCCATCATCGGGGGACATGAGGCC (common for wild 
type and mutant GzmB). 
Wild type GB_Rv: AAAAAAGAATTCTTATTAGTAGCGTTTCATGGTTTTC 
KR243/244AA GB_Rv: AAAAAAGAATTCTTATTAGTAAGCAGCCATGGTTTTC 
KR243/244EE GB_Rv: AAAAAAGAATTCTTATTAGTATTCTTCCATGGTTTTC 
GA_Fw: AAAAAAGGATCCATTATTGGAGGAAATGAAGT 
GA_Rv: AAAAAAGAATTCTTATTAAACTGCTCCCTTGATAGTC 
(PacI) GH_Fw: AAAAAATTAATTAACATCATCGGGGGCCATGAGG 
GH_Rv: AAAAAAGAATTCTTATTAGAGGCGCTTCATTGTTCTC 
GK_Fw: AAAAAAGGATCCATTATTGGAGGGAAAGAAG 
GK_Rv: AAAAAAGAATTCTTATTAATTTGTATGAGGCGGGACAAG 
GM_Fw: AAAAAAGGATCCATCATCGGGGGCCGGGAGG 
GM_Rv: AAAAAAGAATTCTTATTAGGCCGATCGGCCGGTGACC 
 
Effector-target killing assay. 
The 721.221 overexpressing NDUFS1-D255A-V5 (0.1x106) in 50 μl of medium (HBSS 
containing 1.55 mM CaCl2, 17.5 mM glucose, 10 mM Hepes, pH 7.4) were mixed with an 
equal volume of medium containing effector cells (YT-Indy) at the indicated effector:target 
(E:T) ratios and incubated at 370C for the indicated times. For caspase inhibition, target 
cells were pretreated for 30 minutes with 50 μM zVAD-fmk + 50 μM DEVD-fmk before 
incubation with effector cells. Then 5x sample buffer was added, and the sample was 
analyzed by Western blot. 
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For the calcein release assay, Hela expressing CD80, cells were preloaded with 1 μM 
Calcein AM (Life Technologies) for 10 minutes then washed 3 times with HBSS. Then 
1x104 target cells in 100 μl of HBSS containing 1.55 mM CaCl2, 17.5 mM glucose, 10 mM 
Hepes, pH 7.4 5% FCS were incubated with effector cells as done previously for the 
indicated time. Specific killing was determined by monitoring the calcein released in the 
supernatant.  
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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Dox-inducible B2Δ19-HA and Su9-V5 HeLa cells were cultured for 96 hours ± 0.5 μg/mL 
Dox. At 72 hours, 5x103 cells were plated in 96-well plate in 100 μl of medium (DMEM 
with Tet System Approved FBS). The next day, HeLa cells were mixed with an equal 
volume of medium containing effector cells (YT-Indy) at the indicated Effector:Target 
ratios and incubated overnight. Following this, effector cells were washed with HBSS, and 
methylene blue (0.2% methylene in 250ml methanol + 250 ml ddH2O) was added for 30 
minutes at RT. The plates were washed in distilled tap water, and elution was performed 
with 0.1 M HCl. Absorbance was read at 630 nm. 
HeLa Tom40 and Sam50 shRNA cells were cultured for three days ± 1 μg/ml Dox. At day 
2, 3x103 cells were plated in 96-well plate coated with 10 μg/ml laminin. The next day, 
HeLa cells were incubated eight hours with an equal volume of medium containing effector 
cells (YT-Indy, YT-wtGB, YT-GA, YT-GM) at the indicated Effector:Target ratios. Effector 
cells were then washed away with HBSS, and PrestoBlue™Cell Viability Reagent 
(Invitrogen) was added to cells in culture medium. Absorbance was read 16 hours later at 
570 nm.  
 
ROS measurement in target cells during killer cell attack 
HeLa-CD80 target cells were stained with 1uM cellTrace CFSE in HBSS during 15 min, 
then washed three times in HBSS and resuspended at 100 000 cells/ml in assay buffer 
(HBSS, 10mM Hepes pH7.4, 17.5mM Glucose, 1.55mM CaCl2, 10% FBS). For each 
condition, 100 μl of CFSE-labelled target cells were incubated with 100 μl of assay buffer 
containing the appropriate number of YT Indy effector cells. After 2 hours at 370C, cells 
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were placed on ice and every single tube was incubated with 5 μM dihydroethidium (DHE) 
(ThermoFisher) for exactly 4 min at room temperature before analysis on a CyAn flow 
cytometer (Beckman Coulter). Dihydroethidium fluorescence signal intensity was 
analyzed after gating on CFSE-positive cells. 
 
Cell death induction by UV or CH11  
Hela Sam50sh or Hela Tom40 sh were induced for 4 days with 2μg/ml doxycycline (Dox) 
renewed every 2 days, then seeded on the 3rd day in a 96well-plate at 3000 cells/well in 
100ul of DMEM. Dox was kept where required. Cell were either expose to 5 minutes UV 
and incubated for 16 hours. In some cases cells were treated with 2.5 μg/ml cycloheximide 
for 1h before adding 1 μg/ml of CH11 for 6 hours. Cell death were assessed by methylene 
blue staining as before. 
 
In vivo experiments 
U251 glioma cells constitutively expressing renilla luciferase were subcutaneously 
implanted to 4-6 weeks female hairless NOD.Cg-PrkdcscidHrhr/NCrHsd mice (Invigo) at 
2x106 cells/mice in 250μl of PBS. Three days post implantation, tumor size was analyzed 
by bioluminescence. At day 8 post implantation, some animals received 107 YT-shGzm, 
YT-wtGB or YT-KR/AA GB killer cells as indicated. Tumor size was followed at day 10 
and day 17 post implantation. For bioluminescence analysis of the tumor size, mice were 
anesthetized by inhalation of 4% isoflurane and injected with 0.1 mg/g body weight of 
ViviRen in vivo renilla luciferase substrate (Promega). Mice were immediately placed in 
the IVIS Spectrum heated plate (PerkinElmer) and image acquire using Living Image 4.5 
acquisition software (PerkinElmer) with continuous isoflurane anesthesia (1,5 et 2,5% 
during all the acquisition time). Following acquisition mice were monitored until they 
recover from anesthesia before returning them to the housing facility. Quantification of the 
bioluminescence imaging (BLI) signal was performed with the same software. Mice were 
monitored daily for any sign of suffering in which case they were sacrificed. This study 
was carried out in strict accordance with the Swiss Regulation and the protocol was 
Chiusolo et al   12 
approved by the Cantonal Commission for Animal Experiment of the Directorate General 
for Health of the Department of Employment, Social Affairs, and Health. The specific 
permit number for this study is: GE/142/15. The animals (typically 5 animals per cage; 
minimum floor space per animal 13 cm2) were kept under controlled environmental 
conditions in the specific pathogen free animal facility with a 12L:12D cycle. Mice were 
housed in enriched IVC cages containing autoclaved bedding, nesting material and a 
smart home. They were provided with irradiated food and 0.22 μm filtered tap water. Mice 
were under ocular inspection of their general health by animal facility dedicated staff and 
veterinary support is available if needed. At the end of the experiment the animals were 
humanely killed by lethal injection of 150 mg/kg of pentobarbital intraperitoneally. The 
lethal dose of pentobarbital prevent any suffering of the animal since with this procedure 
the animal die under profound anesthesia. n = 5mice/group. 
 
Gram-staining  
Gram staining was performed to determine the optimal condition of treatment with 
lysozyme for removing L. lactis cell wall before import assay. After treatment with 
lysozyme, bacteria were washed with PBS, transferred on a glass slide, air-dried and heat-
fixed over a gentle flame. Fixed cells were stained with crystal violet for 1 min, gently 
washed with water and stained again with Gram’s iodine for 3 min. After a gentle wash 
with water, bacteria were quickly decolorized with 95% ethanol and washed with water 
before counterstaining with safranin for 1 min. Cells were washed with water and air-dried 
before examination under the microscope. 
 
Cell fractionation. 
Cells (0.5x106) were washed in PBS and resuspended in 100 μl of cytosolic extraction 
buffer (70 mM KCl, 137 mM NaCl, 1.4 mM KH2PO4 pH 7.2, 4.3 mM Na2HPO4, 250 mM 
Sucrose, 400 μg/ml digitonin and protease inhibitors) on ice for 5 min, then centrifuged at 
1000 g for 5 min. The supernatant was stored as the cytosolic fraction (C). The pellet was 
resuspended in 100 μl of mitochondrial lysis buffer (50 mM Tris pH7.4, 150 mM NaCl, 2 
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mM EDTA, 2 mM EGTA, 0.22% Triton X-100, 0.3% NP-40, protease inhibitors). After 10 
min centrifugation at 10,000 g, the supernatant was kept as the mitochondrial-enriched 
fraction (M). The Nuclear fraction (N) was obtained after resuspension of the pellet in RIPA 
lysis buffer and sonication. 
 
Recombinant protein purification. 
C-DNA encoding for wild type GB, GB (HIS236A, LYS239/240A) and GB (KR243/244AA) 
with an N-terminal enterokinase site but without His tag, were cloned in pHLSeq vector 
(kind gift of Dr. Radu Aricescu) between AgeI and KpnI restriction sites with the following 
primer sets: 
Common GB_Fw: 
 5’AAAAAAACCGGTGATGATGATGATAAAATCATCGGGGGACATGAGGCC3’ 
GB wild type_Rv: 5’TTATTAGGTACCTTATTAGTAGCGTTTCATGGTTTTCTTTATCC3’ 
GB (H236A-L239/240A)_Rv: 
5’TTATTAGGTACCTTATTAGTAGCGTTTCATGGTAGCAGCTATCCAAGCTACAAAGC
TTGAGACTTTGGTG3’ 
GB (KR243/244AA)_Rv:  
5’ TTATTAGGTACCTTATTAGTAAGCAGCCATGGTTTTCTTTATCCAGTG3’ 
The 293T cells were seeded 150 mm culture dishes to obtain 60-70% confluency the next 
day. One hour before transfection, medium was replaced with new medium without 
antibiotics containing 25 μM chloroquine. Cells were transfected with Calcium-Phosphate 
transfection method. For each dish, 50 μg plasmid DNA was mixed with 0.25M CaCl2 and 
ddH2O to a final volume of 2.5 ml. 2.5 ml of 2x HBS (282 mM NaCl, 50 mM Hepes, 1.5 
mM phosphate sodium; pH: 7.05) were added drop wise to the DNA solution and 
incubated for 2 to 5 minutes at RT. The solution was then sprinkled on the cells and 
incubated for 10 hours. Cells were then rinsed with pre-warmed PBS and serum-free 
medium (ExCell from Sigma) was added for 72 hours. The culture medium was harvested 
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and spun at 400 g to eliminate cells and then spun at 4000 g to eliminate cell debris. 
Granzymes were purified on heparin column according to the method of Thiery et al 
201052. The fractions were screened for granzymes by SDS-gel and coomassie staining. 
The granzyme positive fractions were combined with 1 U porcine enterokinase/20ml and 
dialyzed overnight in 4 liters of enterokinase buffer (150mM NaCl, 1mM Cal, 50mM Tris, 
PH 7.4). Enterokinase from porcine intestine was from Sigma. The next day, dialysis buffer 
was changed for Mono S column buffer A (150 mM NaCl, 50 mM bisTris, pH 5.8) for four 
hours. The solution was then filtered and run on Mono S column according to Thiery et al 
201052. 
 
Purification of native wild type and KR243/244AA GB. 
Native wild type and KR243/244AA GB were purified according to the method of Thiery 
et al 201052 from YT-wtGB and YT-KR243/244AA GB cells, respectively.  
 
Granzyme B activity assay. 
The activity of purified granzyme B was measured by using the chromogenic substrate N-
Acetyl-Ile-Glu-Pro-Asp-p-nitroanilide (Sigma). Granzyme B was diluted at 200 nM in 
HBSS, 10 mM Hepes, pH 7.4 in the presence of 160 μM of substrate in a final volume of 
100 μl, and the absorbance was measured at 405 nm every minute during 45 minutes in 
96-well plates with the SpectraMax Paradigm plate reader (Molecular Devices). 
 
GzmB staining for confocal microscopy 
HeLa-CD80 cells were seeded on laminin-coated coverslips 24 hours before addition of 
YT effector cells at a 2:1 E:T ratio. After 30 min of incubation, cells were fixed with 2% 
PFA for 20 min at room temperature, and for 20 min in the presence of 50 mM NH4Cl. 
Cells were washed with PBS and permeabilized in PBS 0.2% Triton X-100 during 5 min. 
After washes in PBS, cells were blocked for 30 min in PBS 10% FBS, washed again in 
PBS and incubated for 1 hour at room temperature with anti-Granzyme B antibody (1/100 
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in PBS 0.05% Triton X-100) (Invitrogen, clone GB11). Coverslips were washed 3 times 
with PBS and incubated 1 hour at 4°C in PBS 0.05% Triton X-100 containing 1/250 Anti-
mouse IgG (H+L) Alexa Fluor 488 secondary antibody (Molecular Probes). After 3 washes 
in PBS 0.05% Triton X-100 and 2 washed in PBS, coverslips were mounted on glass 
slides with mounting medium containing Dapi. Z-stack images were collected using an 
LSM 700 confocal laser scanning microscope (Zeiss). 
 
Biotinylation of GB and GA.  
 GA and GB 10 μg each were oxidized by 30 minutes incubation in cold 20 mM of freshly 
dissolved sodium Meta-periodate in 100 mM of sodium acetate pH5.5. Excess periodate 
were removed on 7k MWCO Zeba spin desalting column equilibrated with 100 mM sodium 
phosphate buffer pH 7.2. Desalted oxidized granzyme are incubated for two hours at room 
temperature with 5 mM of biotin hydrazide before a last step of desalting to remove excess 
of biotin hydrazide. Final material is concentrated and used in import assay. 
 
Expression of GB-cytoFRET and GB-mitoFRET reporter. 
A human codon optimized synthetic gene encoding ECFP linked to EYFP by the 
VGPDFGR29 GB cleavable linker was cloned between AgeI and PacI restriction sites in 
pQCXIP (Clontech) for GB-cytoFRET reporter. For GB-MitoFRET reporter, three 
mitochondrial targeting sequences of Cox8a were added in frame between NotI and AgeI. 
Sequence of GB-cytoFRET reporter: 
GACCACCGGTAACGCCACCATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGT
GGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTG
TCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCT
GCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCT
GGGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTT
CAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGAC
GACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTG
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AACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGC
ACAAGCTGGAGTACAACTACATCAGCCACAACGTCTATATCACCGCCGACAAGCAG
AAGAACGGCATCAAGGCCAACTTCAAGATCCGCCACAACATCGAGGACGGCAGCG
TGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCT
GCTGCCCGACAACCACTACCTGAGCACCCAGTCCGCCCTGAGCAAAGACCCCAAC
GAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTC
TCGGCATGGACGAGCTGTACAAGTCCGGACTCAGATCTAGCGGCGTGGGCCCCGA
CTTCGGCCGCGTGTACGGCAGCGGCTCCACCATGGTGAGCAAGGGCGAGGAGCT
GTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAAACGGCCA
CAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCTGAC
CCTGAAGCTGATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTG
ACCACCCTGGGCTACGGCCTGCAGTGCTTCGCCCGCTACCCCGACCACATGAAGC
AGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCAT
CTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGC
GACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCA
ACATCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCACC
GCCGACAAGCAGAAGAACGGCATCAAGGCCAACTTCAAGATCCGCCACAACATCG
AGGACGGCGGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCG
ACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCTACCAGTCCGCCCTGAG
CAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCC
GCCGGGATCACTCTCGGCATGGACGAGCTGTACAAGTAATAATTAATTAACGGATC
CGGAATTCCG. 
(AgeI and PacI sites, respectively, are in bold). 
Sequence of 3xCox8a: 
AGGCGGCCGCATGTCCGTCCTGACGCCGCTGCTGCTGCGGGGCTTGACAGGCTC
GGCCCGGCGGCTCCCAGTGCCGCGCGCCAAGATCCATTCGTTGGGGGATCTGTC
CGTCCTGACGCCGCTGCTGCTGCGGGGCTTGACAGGCTCGGCCCGGCGGCTCCC
AGTGCCGCGCGCCAAGATCCATTCGTTGGGGGAtctgTCCGTCCTGACGCCGCTGC
TGCTGCGGGGCTTGACAGGCTCGGCCCGGCGGCTCCCAGTGCCGCGCGCCAAGA
TCCATTCGTTGGGGGATctgGATCCCACCGGTAACGC. 
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(NotI and AgeI sites, respectively, are in bold). 
 
Expression of GA, GB and GM in YT Indy. 
The endogenous granzymes expressed in YT Indy were silenced by transducing the cells 
with lentiviruses generated in 293T cells transfected with the pLVX-shRNA1 vector 
containing GM, GH or GB shRNA together with the lenti-X HTX packaging mix (Clontech). 
Cells were selected with puromycin, and the clones showing the best silencing of all 
granzymes were selected by limiting dilution. For reconstitution of granzyme expression 
in the YT shRNA clones, cells were transduced with lentiviral particles generated from 
pLVX-EF1α expressing GA, GB wt, or GB mutant and selected with blasticidin. The pLVX-
EF1α-blasticidin were generated by swapping puromycin with blasticidin from pLVX-EF1 
EF1α puromycin (Takara).  
Granzyme 3’ UTR target sequences:  
(GB) TATTTATTCAGTTGCTGGC;  
(GM) GGACCAATAAATCATAATG;  
(GH) TATTACAGTCCTGCAACCC. 
Primers for expression of reconstituted GA, GB (wild type and mutants) and GM: 
GA_Fw: AAAAAGCGGCCGCGCCGCCACCATGAGGAACTCCTATAG 
GA_Rv: AAAAAGGATCCTTAAACTGCTCCCTTGATAGTC 
GB_Fw: AAAAAAGCGGCCGCGCCGCCACCATGCAACCAATCCTGCTTC 
Wild type GB_Rv: AAAAAGGATCCTTAGTAGCGTTTCATGGTTTTC 
KR243/244EE GB_Rv: AAAAAGGATCCTTAGTAGGCTGCCATGGTTTTC 
GM_Fw: AAAAAGCGGCCGCGCCGCCACCATGGAGGCCTGCGTGTC 
GM_Rv: AAAAAGGATCCTTAGGCCGATCGGCCGGTGAC 
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B2Δ19-HA and SU9_V5 overexpressing HeLa. 
The pET21+ Cytb2 (1-167) '19 DHFR, and pQE60-Su9 (1-69) DHFR, a kind gift of Dr. 
Dejana Mokranjac, were used as template to subclone B2'19-HA and Su9-V5 between 
the NotI and EcoRI restriction sites of pLVX TRE3G (Takara Clontech) with the following 
set of primers. 
pLVX-TRE3G B2'19 Fw : 
GGCCCGCGGCCGCAATGCTAAAATACAAACCTTTACTAAAAATCTCG 
pLVX-TRE3G B2'19 Rv : 
CCCGGTAGAATTCTCATCAAGCGTAATCTGGAACATCGTATGGGTAAAACTTatACtT
GATGCCTTTTTCC 
pLVX-TRE3G SU9Fw : 
ATCCGGGCCCGCGGCCGCAATGGCCTCCACTCGTGTCCTCGC 
pLVX-TRE3G SU9Rv : 
CCCGGTAGAATTCTTATTACGTAGAATCGAGACCGAGGAGAGGGTTAGGGATAGG
CTTACCAAACTTatACtTGATGCC 
Lentivirus was produced, and HeLa tet cells were transduced following Lenti-X™ Tet-ON® 
3G Inducible Expression System protocol. Dox (1 μg/ml) was added to cell medium for 
B2Δ19-HA and SU9-V5 overexpression.  
Immunoprecipitation. 
C-terminal GzmA residues 232-SKKHLNWIIMTIKGAV-246 or GzmB residues 231-
VSSFVHWIKKTMKRY-245 were fused in C-terminus of two B domains of protein A, BB-
CtA and BB-CtB, respectively. As a control, two BB domains were fused in the C-terminus 
of full length GB to generate GB-BB fusion protein.  
Human codon optimized gblocks for BB domain of protein A were used. 
5'-B/B 
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AAAAAAACCGGTATGGCAGATAATAAGTTTAACAAAGAGCAGCAGAACGCCTTCTA
CGAAATCTTGCACTTGCCTAACCTGAACGAAGAACAGAGAAATGGCTTTATTCAAAG
CCTTAAGGATGATCCGAGCCAGAGCGCTAACCTCCTGGCTGAGGCTAAAAAACTCA
ACGACGCCCAGGCACCTAAAGCTGACAACAAATTTAATAAAGAGCAGCAGAACGCC
TTCTACGAGATACTGCACCTTCCTAATCTCAATGAAGAGCAAAGGAATGGCTTTATT
CAATCTCTGAAGGACGATCCTAGTCAGTCCGCAAACCTGCTGGCCGAAGCGAAGA
AGCTGAACGATGCCCAGGCTCCTAAGGAAAATCTCTATTTCCAAGGGGACGGCGC
GGCCGCGTAATAA 
AgeI and NotI sites are in bold. 
3’-B/B 
AAAAAAGCGGCCGCAGCAGATAACAAGTTCAACAAAGAGCAGCAGAACGCCTTCTA
CGAGATTCTGCATCTGCCGAACCTGAATGAGGAACAGAGAAACGGCTTCATCCAAT
CACTCAAGGATGATCCATCTCAATCCGCAAATCTTCTGGCAGAGGCCAAGAAACTC
AACGATGCGCAGGCCCCCAAGGCGGATAACAAGTTCAACAAAGAGCAGCAGAACG
CCTTCTACGAGATCCTGCACCTTCCCAATCTGAATGAGGAGCAGCGCAACGGTTTC
ATCCAGTCTCTCAAGGACGACCCCAGCCAATCAGCCAACCTCCTCGCAGAAGCTAA
AAAACTTAATGACGCCCAGGCTCCTAAAGGTACCTAATAA 
NotI and KpnI sites are in bold. 
5’ or 3’ BB domains were cloned in pHLsec vector.  
GB cDNA was amplified by PCR and cloned between AgeI and KpnI in pHLsec vector at 
5’ of BB domain of protein A, using the following primers: 
GB-BB AgeI Fw; 
aaaaaaaccggtgatgatgatgataagATCATCGGGGGACATGAGGCC 
GB-BB Rv: 
GATTGCGGCCGCGCCGTCGTAGCGTTTCATGGTTTTCTTTATCC  
C-terminus of GA and GB were cloned between NotI and KpnI.  
CtermA_Fw: 
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AAAAAAGCGGCCGCGTCAAAGAAACACCTCAACTGGATAATTATGACTATCAAGGG
AGCAGTTTAATAAGGTACC AAAAAA 
CtermA_Rv: 
TTTTTTGGTACCTTATTAAACTGCTCCCTTGATAGTCATAATTATCCAGTTGAGGTGT
TTCTTTGACGCGGCCGCTTTTTT 
CtermB_Fw:  
AAAAAAGCGGCCGCGGTCTCAAGCTTTGTACACTGGATAAAGAAAACCATGAAACG
CTACTAATAA GGTACC AAAAAA 
CtermB_Rv: 
TTTTTTGGTACCTTATTAGTAGCGTTTCATGGTTTTCTTTATCCAGTGTACAAAGCTT
GAGACCGCGGCCGCTTTTTT 
 
Purified mouse liver mitochondria (100 μg), were incubated with 2 μg of BB-fused proteins 
in SH buffer (see import assay) for 15 minutes on ice and washed in 1 ml of SH buffer. 
The samples were spun 10 minutes at 12000 g, and the pellet was resuspended in 100 μl 
of SH. The DSP cross-linker (Thermo Fisher) was added at a final concentration of 1 mM 
for 30 minutes at RT and then inactivated by adding 5 μl of 1.5 M Tris, pH 8.0 for 15 
minutes at RT. The samples were spun as before, and the pellet resuspended in 100 μl 
of lysis buffer (50 mM potassium acetate; 10 mM MOPS, 20% glycerol) plus 1% digitonin 
and 10 mM PMSF for 45 minutes at 4°C. 500 μl of lysis buffer was added and the samples 
were spun as previously. The supernatants were incubated O/N at 4°C with Pierce™ 
Streptavidin Magnetic Beads and 15 μl of biotinylated-Fc protein (EZ-link™Sulfo-NHS-
SS-Biotin, Thermo scientific). The next day, beads were washed 2 to 3 times with lysis 
buffer plus 0.2% digitonin, and elution was performed in 100 μl of Glycine-HCl, pH 2.5. 
Samples were loaded on NuPAGE®Novex® 12% Bis-Tris native gel (Life Technologies). 
Gels were silver stained using SilverQuest™ staining kit (Life Technologies), and bands 
of interest were analyzed by mass-spectrometry.  
Statistical Analysis 
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Data represent mean +/- SEM or mean +/- SD of indicated number of independent experiments. 
Statistical significance has been calculated by a two-tailed or one-tailed Student t-test between 
samples and P values are indicated in the legends. 
 
Supplemental Figures: 
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Suppl. Figure 1: GB enters Hela cell mitochondria. Hela cells overexpressing cytosolic (a) or 
mitochondrial targeted (b) GB-FRET reporter were treated with a sublytic dose of perforin 
alone, 0.4 μM of GB alone, or perforin plus 0.4 μM GB. GB activity was monitored by the loss 
of FRET signal by microscopy. Images are representative of three independent experiments. 
(c) GB entered both mouse liver (top raw) and yeast (bottom raw) mitochondria.  
Mitochondria, pretreated or not with valinomycin to disrupt the membrane potential, were 
incubated with Alexa 647-GB before removing the externally bound GB with a gentle 
proteinase K treatment. GB import was analyzed by FACS. FACS histograms are 
representative of three independent experiments. GB enters mouse liver (d) and yeast (e) 
mitochondria in a facilitated manner. Intact or proteinase K pretreated mitochondria were 
incubated with active GB or catalytically inactive s-aGB in import assay. Both active and 
inactive GB only entered intact mitochondria. Western blots are representative of three 
independent experiments. (f) GB enter yeast mitochondrial in a time dependent manner. 
Freshly purified yeast mitochondria were incubated with GB in import assay for the indicated 
time.  
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Suppl. Figure 2: TOM receptors are not required for GB mitochondrial import. (a-d) Non-
labelled B2'19-DHFR and SU9-DHFR, in the absence (a and c) or presence of 
preincubation with methotrexate (b and d) were used to saturate mouse liver mitochondrial 
import machinery before testing the import of 35S-Met labelled SU9-DHFR as a positive 
control (a-b) or GB (0.2 μM) import (c-d). While B2'19-DHFR and SU9-DHFR prevent the 
import of 35S-Met SU9-DHFR, only B2'19-DHFR at the highest dose has an effect on GB 
import. This effect was no longer perceptible in the presence of methotrexate (MTX). (e) 
Mitochondria purified from wild type yeast, or yeast deficient for Tom70 ('Tom70), 
overexpressing Tom70 (Tom70-HA), or deficient for Tom22 in a Tom70 over-expressing 
background ('Tom22), were used in import assay for 35S-Met SU9-DHFR. (f) Same as in 
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(e) using mitochondria purified from wild type, Tom20 overexpressing (Tom20-HA), or 
deficient ('Tom20) yeast strains. (g) Same as in (e) for GB import. Loss of Tom70 and 
Tom22 had no effect on GB import. (h) Same as in (f) for GB import. Loss of Tom20 had 
no effect on GB import. Blots and autoradiographies are all representative of three 
independent experiments.  
 
Suppl. Figure 3: Por1/VDAC deletion affect both SU9 and GB import. (a) C-terminal 
portion of GB or GA were fused to the C-terminus of two B domains of protein A to 
generate the fusion constructs BB-CtB and BB-CtA respectively that were used to carry 
affinity purification. GB with C-terminus blocked with two B domains of protein A (GB-BB) 
was used as negative control. Boxes highlight bands were characterized by mass 
spectrometry. (b) Mitochondria purified from YPH499 wild type or M22-2-1 yeast deficient 
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for Por1 and 2 were used in import of GB (0.2 μM). (c) Same as in (b) mean +/- SD of four 
independent experiments. (d) YPH499 wild type and M22-2-1 yeast mitochondria were 
used in 35S-Met SU9 import. (e) Purified mitochondria from YPH499 an M22-2-1 yeast 
strains were analyzed by FACS for their membrane potential following JC-1 staining. (f) 
Mouse liver mitochondria preincubated or not with VDAC1 inhibitor S-18 were used in GB 
import. (g) Same as in (f), mean +/- SD of three independent experiments. (h) Same as in 
(f) using 35S-Met SU9. (i) Same as in (h), mean +/- SD of three independent experiments. 
P value * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 (two-sided t-test). Blots and autoradiographies 
are all representative of at least 3 independent experiments. 
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Suppl. Figure 4: Tob55/Sam50 is required for GB mitochondrial entry. (a) Mitochondria 
from yeast expressing Tob55/Sam50 under the control of promotor of galactose operon 
grown in galactose or glucose medium were analyzed for Tob55/Sam50, Tom40, Por1 
and TIM23 expression by Western blot. (b and c). Mitochondrial purified as in (a) were 
used to import 35S-Met SU9 (b) or GB (0.2 μM) (c). Loss of Tob55/Sam50 expression has 
no effect on 35S-Met SU9-DHFR import; however, it significantly compromised GB 
mitochondrial entry. Lactococcus lactis (L. lactis) electroporated with construct encoding 
for Por1 (d), Tob55/Sam50 (e) or Tom40 (f) were induced or not with nisin, and the 
expression of Por 1, Tob55/Sam50, and Tom40 tested by Western blot or coomassie blue. 
(g) L. lactis were treated or not with lysozyme, and the integrity of their cell wall tested by 
Gram staining. L. lactis overexpressing Por1 (h) or TOM40 (i) were used in import assay 
for GB. (j) Mitochondria purified from YPH499 wild type yeast or deficient for Tob37 were 
used for the import of GB (0.2 μM). GB entered as efficiently both types of mitochondria. 
Blots are all representative of three independent experiments. 
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Suppl. Figure 5: (a) 3D structure of GB C-terminal tail. Highlighted are residues histidine 
236 and lysines 239-240 (top panel) and residues lysine and arginine 243-244 (bottom 
panel). (b) The five human granzymes enter mitochondria. Hela cells overexpressing 
mitoRFP were co-transfected with either ZsGreen or ZsGreen fused in N-terminus of wild 
type GB, KR243/244AA GB, KR243/244EE GB, wild type GA, GK, GM or GH, and the 
subcellular localization of the granzymes was assessed by confocal microscopy. Images 
are representative of three independent experiments. The wild-type granzymes localized 
to the mitochondria while GB KR243/244AA did not. 
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Suppl. Figure 6: (a) YT-wtGB and YT-KR/AA GB were used to attack Hela CD80+ cells 
expressing either cytosolic (a) or mitochondrial (b) GB-FRET reporter. Images are 
representative of three independent experiments. (c) Parental Y-Indy, YT-shGzm, YT-
wtGB and YT-KR/AAGB were used to kill Hela CD80+ cells. Cell death was assess by 
microscopy. Data represent mean +/- SD of at least four independent experiments. P 
value * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 (one-sided t-test). 
 
 
 
Suppl. Figure 7: Sam50 silence cells are still sensitive to cell death. (a) Hela Sam50sh 
and Hela Tom40sh were Dox-induced or not before 5 minutes exposure to UV irradiation. 
Cell death were assessed 16 hours later by methylene blue staining. (b) Hela Sam50sh 
were Dox-induced or not before treatment with 1 μg/ml of anti-Fas CH11 for 8 hours before 
cell death assessment by methylene blue staining. Data are representative of 3 
independent experiments. 
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Suppl. Figure 8: TOM receptors are not required for GA mitochondrial import. Non-labelled 
B2'19-DHFR and SU9-DHFR in the absence (a) or presence (b) of preincubation with 
methotrexate were used to saturate mouse liver mitochondria import machinery before testing 
the import of GA (0.2 μM). Only B2'19-DHFR at the highest dose had an effect on GA import. 
This effect was no longer perceptible in the presence of methotrexate. (c) Mitochondria 
deficient for Tom70 ('Tom70) overexpressing Tom70 (Tom70-HA) or deficient for Tom22 in a 
Tom70 overexpressing background ('Tom22) were used in import assay for GA (0.2 μM). (d) 
Same as in (c) using mitochondria isolated from wild type, Tom20 overexpressing (Tom20-HA) 
or deficient ('Tom20) yeast strains. Lake of Tom20 had no effect on GA import. Blots are all 
representative of three independent experiments.  
 
 
 
